UWB1.289+BRCA1

规格:

货期:

编号:TS152123

品牌:Testobio

产品名称：	UWB1.289+BRCA1
商品货号：	TS152123
Organism：	Homo sapiens, human
Tissue：	ovary
Product Format：	frozen
Morphology：	epithelial-like
Culture Properties：	adherent
Biosafety Level：	2 Cells contain CMV and SV40 vial DNA sequences Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Disease：	ovarian carcinoma
Age：	56
Gender：	female
Storage Conditions：	liquid nitrogen vapor phase
Images：
Derivation：	UWB1.289+BRCA1 is a stable cell line derived from UWB1.289 (ATCC CRL-2945), a BRCA1-null human ovarian cancer line, in which wild-type BRCA1 was restored.
Clinical Data：	female
Antigen Expression：	BRCA1, positive cytokeratin 7 (CK-7), positive calretinin, positive Wilms tumor protein (WT), positive
Receptor Expression：	estrogen, not expressed progesterone, not expressed
Oncogene：	p53
Genes Expressed：	p53, cytokeratin 7 (CK-7)
Comments：	A pcDNA3 plasmid carrying wild-type BRCA1 was transfected into the parent line. Restoration of wild-type BRCA1 function in these cells partially restores DNA damage responses. RefDelloRusso, C., et al. Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation. Mol Cancer Res.;5(1):35-45, 2007. PubMed: 17259345 Restoration of wild-type BRCA1 function in these cells partially restores DNA damage responses.
Complete Growth Medium：	The base medium for this cell line is: 50% ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. 50% MEGM (Mammary Epithelial Growth Medium from Clonetics/Lonza (MEGM Bullet Kit; CC-3150) made of MEBM basal medium and SingleQuot additives (ATCC does not use gentamycin-amphotericin B). Note: Do not filter complete medium. To make the final complete growth medium add the following components to the base medium: G-418 to a final concentration of 200ug/ml. fetal bovine serum to a final concentration of 3%.
Subculturing：	Volumes used in this protocol are for 75xa0cm² flasks; proportionally reduce or increase amount of dissociation medium for culture vessels of other sizes. Remove and discard culture medium. Briefly rinse the cell layer with Ca++/Mg++ free Dulbeccos phosphate-buffered saline (D-PBS) or 0.25% (w/v) Trypsin - 0.53 mM EDTA solution to remove all traces of serum which contains trypsin inhibitor. Add 2.0 to 3.0 mL of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes). Note: To avoid clumping, do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal. Add 2.0 to 3.0 mL of complete growth medium and aspirate cells by gently pipetting. Transfer cell suspension to a centrifuge tube and spin at approximately 125 X g for 5 to 10 minutes. Discard supernatant. Resuspend the cell pellet in fresh growth medium. Add appropriate aliquots of the cell suspension to culture vessels. An inoculum of 5 x 10³ to 7 X 10³ viable cells/cm² is recommended. Incubate cultures at 37°C. Subculture when cell concentration is between 4 x 10⁴ and 6 x 10⁴ cells/cm². Subcultivation ratio: A subcultivation ratio of 1:4 to 1:6 is recommended. Medium renewal: Every 2 to 3 days
Cryopreservation：	Freeze medium: complete growth medium, 95%; DMSO, 5% Storage temperature: liquid nitrogen vapor phase
Culture Conditions：	Atmosphere: 5% CO₂ in air recommended Temperature: 37°C
STR Profile：	D5S818: 13 D13S317: 9 D7S820: 7, 10 D16S539: 12 vWA: 16, 19 THO1: 9 TPOX: 9, 11 CSF1PO: 11 Amelogenin: X
Population Doubling Time：	approximately 36 hours
Name of Depositor：	E Swisher
Year of Origin：	2003
References：	DelloRusso, C., et al. Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation. Mol Cancer Res.;5(1):35-45, 2007. PubMed: 17259345

首页 > 产品中心 > 微生物培养 > 菌株 > null > UWB1.289+BRCA1

产品中心 Product Center

联系我们CONTACT US

0574-87917803
24小时服务热线
testobio@163.com
销售邮箱
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址

联系方式

章丽敏
17757489010
朱静
18067106081
李晴
18067408036
李晶晶
13375187189
周雪
13372109301

UWB1.289+BRCA1

货号: TS152123
好评

有货

品牌 : TESTOBIO

加入购物车在线咨询

产品名称：	UWB1.289+BRCA1
商品货号：	TS152123
Organism：	Homo sapiens, human
Tissue：	ovary
Product Format：	frozen
Morphology：	epithelial-like
Culture Properties：	adherent
Biosafety Level：	2 Cells contain CMV and SV40 vial DNA sequences Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Disease：	ovarian carcinoma
Age：	56
Gender：	female
Storage Conditions：	liquid nitrogen vapor phase
Images：
Derivation：	UWB1.289+BRCA1 is a stable cell line derived from UWB1.289 (ATCC CRL-2945), a BRCA1-null human ovarian cancer line, in which wild-type BRCA1 was restored.
Clinical Data：	female
Antigen Expression：	BRCA1, positive cytokeratin 7 (CK-7), positive calretinin, positive Wilms tumor protein (WT), positive
Receptor Expression：	estrogen, not expressed progesterone, not expressed
Oncogene：	p53
Genes Expressed：	p53, cytokeratin 7 (CK-7)
Comments：	A pcDNA3 plasmid carrying wild-type BRCA1 was transfected into the parent line. Restoration of wild-type BRCA1 function in these cells partially restores DNA damage responses. RefDelloRusso, C., et al. Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation. Mol Cancer Res.;5(1):35-45, 2007. PubMed: 17259345 Restoration of wild-type BRCA1 function in these cells partially restores DNA damage responses.
Complete Growth Medium：	The base medium for this cell line is: 50% ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. 50% MEGM (Mammary Epithelial Growth Medium from Clonetics/Lonza (MEGM Bullet Kit; CC-3150) made of MEBM basal medium and SingleQuot additives (ATCC does not use gentamycin-amphotericin B). Note: Do not filter complete medium. To make the final complete growth medium add the following components to the base medium: G-418 to a final concentration of 200ug/ml. fetal bovine serum to a final concentration of 3%.
Subculturing：	Volumes used in this protocol are for 75xa0cm² flasks; proportionally reduce or increase amount of dissociation medium for culture vessels of other sizes. Remove and discard culture medium. Briefly rinse the cell layer with Ca++/Mg++ free Dulbeccos phosphate-buffered saline (D-PBS) or 0.25% (w/v) Trypsin - 0.53 mM EDTA solution to remove all traces of serum which contains trypsin inhibitor. Add 2.0 to 3.0 mL of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes). Note: To avoid clumping, do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal. Add 2.0 to 3.0 mL of complete growth medium and aspirate cells by gently pipetting. Transfer cell suspension to a centrifuge tube and spin at approximately 125 X g for 5 to 10 minutes. Discard supernatant. Resuspend the cell pellet in fresh growth medium. Add appropriate aliquots of the cell suspension to culture vessels. An inoculum of 5 x 10³ to 7 X 10³ viable cells/cm² is recommended. Incubate cultures at 37°C. Subculture when cell concentration is between 4 x 10⁴ and 6 x 10⁴ cells/cm². Subcultivation ratio: A subcultivation ratio of 1:4 to 1:6 is recommended. Medium renewal: Every 2 to 3 days
Cryopreservation：	Freeze medium: complete growth medium, 95%; DMSO, 5% Storage temperature: liquid nitrogen vapor phase
Culture Conditions：	Atmosphere: 5% CO₂ in air recommended Temperature: 37°C
STR Profile：	D5S818: 13 D13S317: 9 D7S820: 7, 10 D16S539: 12 vWA: 16, 19 THO1: 9 TPOX: 9, 11 CSF1PO: 11 Amelogenin: X
Population Doubling Time：	approximately 36 hours
Name of Depositor：	E Swisher
Year of Origin：	2003
References：	DelloRusso, C., et al. Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation. Mol Cancer Res.;5(1):35-45, 2007. PubMed: 17259345